Doug Hampton

Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagnosed glioblastoma USA – English India – English

by

The independent data monitoring committee (IDMC) has recommended continuation of CLINGLIO without modification after its assessment of LAM561 interim efficacy in newly diagnosed Glioblastoma. This follows the previous recommendation in relation to safety. CLINGLIO remains on track to have its open readout at 66 progression events, expected in summer 2024. PALMA DE MALLORCA, Spain, March … Read more

Innovent and AnHeart Therapeutics Announce the NMPA of China Has Accepted Second NDA for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer USA – English APAC – Traditional Chinese APAC – English

by

ROCKVILLE, Md. and SUZHOU, China, March 5, 2024 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, and AnHeart Therapeutics (“AnHeart”), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, … Read more

Hybribio Calls for Raising International HPV Awareness

by

GUANGZHOU, China, March 4, 2024 /PRNewswire/ — March 4th 2024 marks the 7th International HPV Awareness Day, a global campaign proposed by the International Papillomavirus Society (IPVS) since 2018. This year, the theme is One Less Worry. On this special day, Hybribio (300639.SZ) calls for raising international HPV awareness and adopting effective strategies for early … Read more

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioNTech SE of Class Action Lawsuit and Upcoming Deadlines

by

NEW YORK, March 3, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against BioNTech SE (“BioNTech” or the “Company”) (NASDAQ: BNTX). The class action, filed in the United States District Court for the Central District of California, and docketed under 24-cv-00337, is on behalf of a class consisting of … Read more

How Election Season Can Affect Mental Health and What To Do About It

by

SACRAMENTO, Calif., March 2, 2024 /PRNewswire/ — With Super Tuesday around the corner and the next presidential election looming, many of us are feeling our anxiety rise. If you’ve found yourself tossing and turning at night, unable to relax the tension in your shoulders, or even having stomach discomfort, you’re not imagining things: you might be … Read more

Conventional Therapies Leave Considerable Unmet Needs, Novel Treatments Offer a Ray of Hope

by

DUBLIN, March 1, 2024 /PRNewswire/ — The “Acute Heart Failure (AHF) Therapeutics: Global Strategic Business Report” report has been added to  ResearchAndMarkets.com’s offering. Global Acute Heart Failure (AHF) Therapeutics Market to Reach $2.9 Billion by 2030 The global market for Acute Heart Failure (AHF) Therapeutics estimated at US$599.7 Million in the year 2022, is projected to … Read more

La devaluación del impuesto sobre el alcohol podría rescatar al sistema estatal de California

by

Hay que pedirle al gobernador Newsom que aumente el impuesto especial sobre el alcohol de California para arreglar la financiación de Cal State y salvar las vidas de los estudiantes. SAN RAFAEL, California, 29 de febrero de 2024 /PRNewswire-HISPANIC PR WIRE/ — Alcohol Justice hace un llamamiento al gobernador de California Gavin Newsom para que el … Read more

Vapotherm’s HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America’s Largest Health Care Market

by

EXETER, N.H., Feb. 29, 2024 /PRNewswire/ — Vapotherm, Inc. (OTCQX: VAPO), (“Vapotherm” or the “Company”), a global medical technology company specializing in the development and commercialization of its proprietary Vapotherm high-velocity therapy® products for patients of all ages experiencing respiratory distress, is pleased to announce the regulatory approval of the HVT 2.0 system in Brazil. … Read more

Learn CPR as a Life-Saving Skill

by

MISSION, Kan., Feb. 28, 2024 /PRNewswire/ — (Family Features) While many Americans agree Conventional CPR (cardiopulmonary resuscitation) or Hands-Only CPR (HOCPR) significantly improve a person’s chance of survival from cardiac arrest, less than half are confident they can perform either Conventional CPR or HOCPR in an emergency. Photo courtesy of Shutterstock Black or Hispanic adults … Read more

Updated notice to attend the extraordinary general meeting of Minesto AB (publ)

by

GOTHENBURG and VÄSTRA GÖTALAND, Sweden, Feb. 27, 2024 /PRNewswire/ — The Board of Directors in Minesto AB (publ) has resolved to convene the Extraordinary General Meeting on Thursday, 14 March 2024, instead of Wednesday, 13 March 2024. The reason for the new date is to ensure that the General Meeting can be conducted in a formally … Read more